JP2024515215A5 - - Google Patents
Info
- Publication number
- JP2024515215A5 JP2024515215A5 JP2023565466A JP2023565466A JP2024515215A5 JP 2024515215 A5 JP2024515215 A5 JP 2024515215A5 JP 2023565466 A JP2023565466 A JP 2023565466A JP 2023565466 A JP2023565466 A JP 2023565466A JP 2024515215 A5 JP2024515215 A5 JP 2024515215A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- compound
- dosage form
- oral dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181492P | 2021-04-29 | 2021-04-29 | |
| US63/181,492 | 2021-04-29 | ||
| PCT/IB2022/053973 WO2022229907A1 (en) | 2021-04-29 | 2022-04-28 | Antimicrobial and anticancer agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515215A JP2024515215A (ja) | 2024-04-05 |
| JP2024515215A5 true JP2024515215A5 (https=) | 2025-04-30 |
Family
ID=81598080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565466A Pending JP2024515215A (ja) | 2021-04-29 | 2022-04-28 | 抗菌剤及び抗癌剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12612375B2 (https=) |
| EP (1) | EP4330238A1 (https=) |
| JP (1) | JP2024515215A (https=) |
| KR (1) | KR20240004303A (https=) |
| CN (1) | CN117295720A (https=) |
| AU (1) | AU2022267897A1 (https=) |
| CA (1) | CA3216783A1 (https=) |
| IL (1) | IL307990A (https=) |
| WO (1) | WO2022229907A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024177036A1 (ja) * | 2023-02-20 | 2024-08-29 | 大鵬薬品工業株式会社 | Ｆｔｄ・ｔｐｉ配合剤、ｐｄ－１経路アンタゴニスト、及びｖｅｇｆ経路アンタゴニストの併用 |
| WO2026074499A1 (en) * | 2024-10-03 | 2026-04-09 | Geistlich Pharma Ag | Methods and compositions for inhibiting c-myc |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1160443B (de) * | 1961-11-30 | 1964-01-02 | Hoechst Ag | Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden |
| GB8617482D0 (en) | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| PT2861573T (pt) | 2012-06-18 | 2017-11-14 | Geistlich Pharma Ag | Derivados de oxatiazina como agentes antibacterianos e anticancerígeno |
| KR102594322B1 (ko) * | 2014-12-19 | 2023-10-26 | 가이스틀리히 파마 아게 | 옥사티아진-유사 화합물의 제조방법 |
| US20220313702A1 (en) | 2019-05-22 | 2022-10-06 | Geistlich Pharma Ag | Oxathiazin compounds for inhibiting gapdh |
-
2022
- 2022-04-28 AU AU2022267897A patent/AU2022267897A1/en not_active Abandoned
- 2022-04-28 WO PCT/IB2022/053973 patent/WO2022229907A1/en not_active Ceased
- 2022-04-28 KR KR1020237035237A patent/KR20240004303A/ko active Pending
- 2022-04-28 CA CA3216783A patent/CA3216783A1/en active Pending
- 2022-04-28 JP JP2023565466A patent/JP2024515215A/ja active Pending
- 2022-04-28 EP EP22722576.0A patent/EP4330238A1/en active Pending
- 2022-04-28 US US18/556,480 patent/US12612375B2/en active Active
- 2022-04-28 CN CN202280031909.6A patent/CN117295720A/zh active Pending
- 2022-04-28 IL IL307990A patent/IL307990A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2576289T3 (es) | Nanopartículas de paclitaxel y albúmina en combinación con bevacizumab contra el cáncer | |
| ES2384789T3 (es) | Combinación de un análogo de epotilona y agentes quimioterapéuticos para el tratamiento de enfermedades proliferativas | |
| CN107864625B (zh) | 含有取代的2,3-二氢咪唑并[1,2-c]喹唑啉的组合产品 | |
| AU2001252442B2 (en) | Combination chemotherapy | |
| CN115624550B (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| CN102089007A (zh) | (a)磷酸肌醇3-激酶抑制剂和(b)ras/raf/mek通路调节剂的组合产品 | |
| JP2020183440A5 (https=) | ||
| RS58609B1 (sr) | Kombinovana terapija sa inhibitorom mitoze | |
| JP2003533485A5 (https=) | ||
| CN112218639A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物的组合组合物和其使用方法 | |
| KR20220003560A (ko) | 유잉 육종의 치료를 위한 퀴놀린 화합물 또는 그의 약제학적으로 허용 가능한 염 | |
| JP2024515215A5 (https=) | ||
| JP2010043115A (ja) | 腫瘍転移および癌の治療における５−フルオロウラシルの有効性の増強 | |
| JP2021523189A (ja) | ビスフルオロアルキル−１，４−ベンゾジアゼピノン化合物を含む組成物およびその使用方法 | |
| CN111558044A (zh) | 一种包含舒尼替尼的药物组合物及其制剂和应用 | |
| JP2009536956A (ja) | 抗癌治療法 | |
| IL307990A (en) | Antimicrobial and anticancer agents | |
| KR20100054210A (ko) | 암 치료를 위한 육산화사비소의 병용요법 | |
| MXPA04006822A (es) | Combinaciones que comprenden epotilonas y anti-metabolitos. | |
| EA006295B1 (ru) | Применение производных дистамицина для противоопухолевой терапии | |
| TWI598095B (zh) | 治療或緩解高齡或末期癌症患者用之醫藥組合物 | |
| WO2021048417A1 (en) | Combination therapies comprising dasatinib for the treatment of cholangiocarcinoma | |
| CN101155600B (zh) | 放射线治疗增强剂 | |
| AU2008356312B2 (en) | Antitumor agent, kit, and method for treating cancer | |
| CN116672345A (zh) | Parp抑制剂和细胞毒性剂的联合产品及其用途 |